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1. Introduction
   Bees are flying insects in the order Hymenoptera and are 
closely related to wasps and ants. Asides their important 
ecological and economic role in the pollination of natural 
and commercial plant species[1], respectively, they are also 
known commercially for their role in producing natural 
products. In addition to honey, commercial bee products 
also include beeswax, bee pollen, royal jelly and propolis[2]. 
Each of these different bee products are, or are becoming, 
economically important and additionally are known to 
have several potent bioactivities. Indeed, bee products 
have been used in traditional medicine throughout society. 
For instance, bee pollen is reported to boost energy and 
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Bee products have long been used in traditional medicine. The raw materials, crude extracts 
and purified active compounds from them have been found to exhibit interesting bioactivities, 
such as antimicrobial, anti-inflammatory and antioxidant activities. In addition, they have been 
widely used in the treatment of many immune-related diseases, as well as in recent times in 
the treatment of tumors. Bee product peptides induce apoptotic cell death in vitro in several 
transformed (cancer) human cell lines, including those derived from renal, lung, liver, prostate, 
bladder and lymphoid cancers. These bioactive natural products may, therefore, prove to be 
useful as part of a novel targeted therapy for some types of cancer, such as prostate and breast 
cancer. This review summarizes the current knowledge regarding the in vivo and in vitro potential 
of selective bee products against tumor cells.
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stamina[3], propolis to help maintain good health[4], royal 
jelly to support the immune system and increase energy[5], 
whilst honey, mainly used as a natural sweetener in every 
food culture, is also used traditionally used for treatment 
of burns, sore throats and as an antiseptic[6]. More recent 
studies have found that several bee products have a 
potential anticancer activity in vitro and in vivo[7].
   Several recent studies have reported that some natural 
bee products inhibit tumour cell growth and metastasis and 
induce apoptosis of cancer cells[8], suggesting the potential 
application of these natural compounds (or their active 
components) as part of an alternative medical treatment of 
human tumours[7]. When chemo- and radio-therapy are 
used systemically or over a broad directed tissue area to kill 
cancerous cells, they also typically harm healthy cells in 
the process causing undesirable side effects that limit the 
treatment (duration and/or dose) and effectiveness, or in the 
worst cases can kill the patient faster than the cancer would 
have done. Accordingly, research for alternative anticancer 
drugs has become a popular topic, especially for natural 
products. Natural products are viewed as generally being 
weaker but much safer. There is some element of validity 
in this approach in that, although some natural products 
are as toxic to normal cells, others do not directly interact 
with the cells but rather activate the immune system and 
so rely on the natural immune discrimination between 
healthy and infected or transformed cells. Alternatively, 
some natural products differentially act upon transformed 
and normal cells. Moreover, natural sources are a rich and 
largely untapped resource of potentially new agents against 
such diseases. For example, the origin of mostly current 
anticancer drugs is in one way while the rest are from natural 
sources[9], yet the diversity of such natural compounds 
remains relatively unknown. Although relatively few of the 
actual isolated compounds advance to become clinically 
effective drugs in their own right, they may serve as a 
template for the preparation of more efficacious analogues 
using total or combinatorial synthesis, or manipulation of 
biosynthetic pathways[9].
   During the past two decades, the simple and polyphenolics 
plus peptides from bee products have started to attract more 
attention for their potential use in cancer therapy. This 
review aims to summarize the anticancer activity of bee 
products.
2. Honey and cancer
   For centuries, honey has been known for its medicinal and 
health promoting properties. Honey is a complex produced 
by various species of honey bees (Apis sp.) from the nectar 
of plant blossoms or the exudates of plant phloem feeding 
insects (honeydew), or a mixture of both. These differences 
in direct and indirect (via phytophagous insect exudates) 
botanical sources, as well as the different foraging strategies 
of different bee isolates/species give rise to the seasonal, 
biogeographic (regional) and species specific variations 
in different honeys[10]. Although honey is principally a 
concentrated aqueous solution of inverted sugars (glucose 
and fructose), it aslo containes other saccharides, amino 
acids, organic acids, vitamins, minerals, antioxidants, 
flavonoids, phenolic acids and carotenoids [11-13]. Of the 
various kinds of phytochemicals present in honey, the 
phenolic and flavonoid content are relatively high and are 
comprised of simple and polyphenols, such as acacetin, 
apigenin, caffeic acid, caffeic acid phenethyl ester (CAPE), 
chrysin, galangin, kaemfereol, pinocembrin, pinobanksin 
and quercetin[14] that contribute to its antioxidant 
activity[12,15,16]. Flavanoids typically have anticancer 
properties[17] because of their antioxidant activity and also 
their related ability to alter many signalling pathways, 
including stimulation of tumor necrosis factor-alpha (TNF-α), 
inhibition of cell proliferation, induction of apoptosis, 
and cell cycle arrest[18-22]. Honey is thought to exhibit a 
broad spectrum of therapeutic properties in addition to an 
antioxidant activity, including an antimicrobial activity[19,23-
25], cytostatic and anti-inflamatory activity[24]. Of interest 
here, however, is that honey can provide the basis for the 
development of novel therapeutics for patients with soft 
and hard (tumour) tissue cancers, especially jungle honey 
(wild honey collected from forest regions). In addition to 
affecting the chemotactic induction of neutrophils and 
reactive oxygen species[26], jungle honey has been shown 
to posses a significant antitumor activity in vitro against 
human breast, cervical, oral and osteosarcoma cancer 
derived cell lines[27,28]. However, the in vivo or in vitro 
effect of honey on hormone-dependent human cancers, 
such as breast, endometrial and prostate cancers, as 
well as solid tumour cancers in vivo, remains largely 
unknown. Honey has moderate anti-tumour activity 
and anti-metastatic effects against renal cell carcinoma 
and rat and murine tumours[22,29-31], and potentiated the 
effect of standard chemotherapy with 5-flourouracil or 
cyclophosphamide[32]. Some of the principal phytochemicals 
in honey (epigallocatechin-gallate, lycopene, genistein 
and resveratrol) have been used for treatment of prostate 
cancer [33,34], although the exact relative composition will 
vary between different regional, season and botanical 
source of the honey. There is increasing evidence to support 
that honey is a natural anti-inflammatory, antimicrobial, 
anticancer agents and potential for healing chronic ulcers 
and wounds[35]. Whilst the antibacterial effects of neat or 
high concentration honey are likely to be largely due to 
its osmotic potential, the in vitro and in vivo anti-cancer 
effects are usually seen at much lower concentrations (e.g. 
IC50 values of 100-200 µg/mL) even before systemic dilution 
in the tissue and so are more likely to reflect the actual 
bioactivities of its trace components. To this end, honey is 
known to contain caffeic acid, CAPE and flavonoid aglycones 
that downregulate many cellular enzymatic pathways, 
including protein tyrosine kinases, cyclooxygeneses and 
ornithine decarboxylase[36]. However, it should be born in 
mind that in addition to the above anti-proliferation and 
anti-metastic effects plus the induction of apoptosis in 
tumour cells, honey has, in contrast, been reported to induce 
the proliferation of malignant cells, albeit that this was 
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under possible nutrient limited conditions[19,37,38]. 
   The mechanisms of action of honey in reducing tumour 
proliferation have been reported to broadly be via enhancing 
the immune response aginst the tumour cells. For example, 
honey increased the production of interleukin (IL)-1B, IL-6 
and TNF-α in the human monocytic cell line, MM6, as well 
as primary human monocytes[19,39], increased secondary 
immune response antibody production[40], and enhanced 
neutrophil curculation and chemotaxis to the tumour[26]. 
Other diverse mechanisms are reported to include the 
modulation of signalling pathways[18] including TNF-α[19], 
inhibition of cell proliferation and induction of apoptosis[20], 
cell cycle arrest[21] and inhibition of lipoprotein oxidation[41]. 
However, the ability of honey to induce a reduced tumor 
growth or to inhibit metastasis was reported to be dependent 
upon the time of treatment, being an effective prophylactic 
but somewhat ineffective treatment agent [31].
   It is of note that honey and cancer have a potentially 
sustainable inverse relationship in developing countries, 
where resources for cancer prevention and treatment are 
limited but honey can be plentiful[42].
3. Anticancer activity of propolis
   Propolis (bee putty or bee glue) is produced by bees 
from the resin collected from trees and shrubs[43], which 
is combined with beeswax and secretions from the bee’s 
salivary glands (rich in enzymes) plus some pollen. The 
color varies from yellow, brown or black, depending on the 
plants that the resinous substance was collected from, and 
so will vary with the local flora (geographical location and 
season) and foraging preferences (bee species). There is 
a long history of the recorded use of propolis by humans, 
dating back at least as far as the Egyptians who used it for 
embalming the body as an antibacterial tool[44]. Propolis, 
just like honey, has been the subject of many studies due to 
its antimicrobial, antifungal, antiviral and hepatoprotective 
activities[45]. More recently, propolis has been investigated 
for its potential anticancer activities[20-22].
   Propolis is a rich mixture of polyphenols, flavonoid 
aglycones, phenolic acids and their esters and phenolic 
aldehydes and ketones. As with all bee products, the 
exact composition will vary with the plants sampled and 
so also shows a biogeographic, seasonal and bee-species 
specificiy[46-49]. Polyphenolic compounds are known to have 
anticarcinogenic activity on murine tumor models[31,50-54]. In 
addition, caffeic acid, CAPE and quercitin can inhibit cancer 
cell growth[55-57]. Artepillin C, isolated from propolis, was 
reported to induce cytotoxicity of carcinomas and malignant 
melanoma cells by apoptosis, abortive mitosis and mass 
necrosis. The tumor growth suppression was likely to be 
due to its own direct cyctotoxicity as well as enhanced 
immunity[51] and inhibition of lipid peroxidation[52]. Other 
studies have shown that three different propolins (A-C) 
induce apoptosis in human melanoma cells[58], whilst 
another compound from propolis (PM3) inhibits the in 
vitro growth of MCF-7 breast cancer cells and induces 
apoptosis[59].
   One positive effect of anticancer therapy is the ability 
to initate apoptosis (regulated cell death) in cancer 
cells[60], and especially if specifically in cancer cells. 
Apoptosis is a natural mechanisim to regulate cell death 
in various developmental and functional stages. There 
are two main pathways of apoptosis. The first is induced 
by an external signal stimulated by TNF receptors, TNF-
related apoptosis-inducing ligand (TRAIL)-R1 or death 
receptor 4 (DR4), and TRAIL-R2 (DR5). The second pathway 
is mediated by mitochondria and pro-apoptotic proteins, 
including cytochrome c[61]. The interest in propolis for 
anticancer therapeutics is due to its apparent ability to 
induce apoptosis, although the mechanism induced seems 
to be dependent on the type and concentration of the 
propolis extract[62]. Recent studies have suggested that the 
astaxanthin and flavonoids in propolis can protect SH-
SY5Y cells (an adenergic cell line derived from a human 
neuroblastomic bone marrow) from beta-amyloid induced 
apoptotic death[63].
   In vitro exposure to the water-soluble extracts of propolis 
(WSP) increased was more effective against tumour growth 
and metastasis when given before tumor innoculation 
(prophylatic)[63-65] and had a strong antimetastatic effect 
upon the percentage of apoptotic rat hepatoma MCA cells 
from 20% (control) to 25% after exposure to 50 µg/mL of WSP 
for 15 h, but the percentage of apoptotic Chinese hamster 
lung fibroblast carcinoma V79 cells treated with the same 
WSP was much smaller at 10%, indicating the potential 
different degrees of sensitivity to propolis amoung cancer 
cells and normal fibroblasts[64,65]. Other studies have shown 
that propolis may induce apoptosis through activating the 
caspase-dependent pathway[66]. The caspase inhibitor 
Z-Asp-CH2-DCB could completely prevent the in vitro DNA 
fragmentation stimulated by propolis in the U937, J447.1, 
Ps88, HL-60 and Jurkat leukemia cell lines, suggesting that 
the effect is not cell-specific[66].
   The mechanism of propolis-induced apoptosis appears 
to be independent of the kind of cancer cells studied, but 
dependent on the concentration of the propolis extract. 
Thus, several studies have reported that propolis induces 
apoptosis through the release of cytochrome c from the 
mitochondria to the cytosol, through the caspase cascade 
and TRAIL signals[67].
   Of the active compounds found so far in propolis, CAPE 
and chrysin appear to play a key role. CAPE exhibits strong 
antitumor effects in oral cancer cells, including the neck and 
tongue, and many proteins involved in the apoptotic process 
are affected by CAPE[68]. The mechanisms of inhibition of the 
activity of p53, p21, p38 mitogen-activated protein kinase 
(p38 MAPK) and c-Jun N-terminal kinase in tumour cells by 
CAPE[69,70], appear to result from the inhibition of nuclear 
factor kappa-light-chain-enhancer of activated B cells 
(NF-κB) that is associated with the down regulation of the 
inhibitors of apoptotic proteins (IAPs), such as cIAP-1 and 
cIAP-2 expression[71].
   Chrysin, another bioactive component of honey that is also 
found at higher concentrations in propolis, has been shown 
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to have significant biological and pharmacological properties 
that include antioxidant and anti-inflammatory effects[72], 
as well as an anticancer property[73]. Chrysin influences the 
apoptotic process in many types of cell lines, especially 
leukemia, and induces apoptosis in these cells by activation 
of caspases, suppression of anti-apoptotic proteins, such as 
IAPs, cellular FLICE-like inhibitory protein, phosphoinositide 
3-kinase (PI3K)/Akt signal pathway, and the inhibition of IκB 
kinase and NF-κB[73].
   In conclusion, the induction of apoptosis in various cancer 
cells by propolis extracts (WSP) and its enriched active 
compounds, such as CAPE and chrysin, are dependent on 
the concentration of the products used. Propolis appears 
to induce apoptosis through the release of cytochrome c 
from the mitochondria to the cytosol, mediated through the 
caspase cascade and activation of pro-apoptotic proteins. 
4. Royal jelly inhibition of N-acetyltransferase (NAT) 
activity in tumor cells
   Arylamine carcinogens can induce some tumors in 
humans, but these carcinogens require further metabolic 
activation to be able to exert genotoxicity within the target 
organs. N-acetylation is one of the metabolic pathways that 
activate arylamine carcinogens and is also believed to be 
an important step in arylamine metabolism. N-acetylation 
catalyzed by NAT requires acetyl coenzyme A as its cofactor, 
and is an important enzyme in the biotransformation and 
metabolism of various drugs and compounds that may play 
an important role in the etiology of bladder, breast and 
colorectal cancers[74,75]. Indeed, the genes coding for NAT 
(NAT1 and NAT2) are polymorphic and specific variants may 
be related to an increased risk of cancer in individuals.
   Royal jelly, sectreted from the salivary glands of worker 
bees, is a special food that influences the development of 
female bee larvae, where a diet low in royal jelly allows 
the development of larvae into worker bee adults, but 
larvae feed sufficient royal jelly instead develop into queen 
bees[76]. It is comprised of free amino acids, polypeptides, 
sugars, fatty acids (mostly 10-hydroxy-2-decanoic acid), 
minerals and vitamins. In humans, the oral consumption of 
royal jelly is known to decrease the total serum cholesterol 
level, but it can cause an IgE anaphylactic reaction in 
atopic women[77]. Lyophilized royal jelly has been reported 
to prevent hyperlipidermia and improve the coagulaation 
status of blood in rats[78]. Moreover, it has been reported 
that royal jelly has a potential antitumor activity in mice[79]. 
The relationship between royal jelly and N-acetylation in 
the metabolism of 2-aminofluorene (2-AF) was evaluated 
in human liver tumor cells, where cytochrome P450 was 
found to be important in the metabolism of N-acetylated AF 
(2-AAF) by converting N-hydroxy-2-AAF to the mutagenic 
and potentially carcinogenic product R16[80]. Whether royal 
jelly can inhibit cP450 activity in the human hepatocellular 
carcinoma derived J5 cell line is not known, but it decreased 
NAT activity and the N-acetylation of 2-AF cells[80]. In 
another study the administration of royal jelly before or after 
a tumor transplant was found to be ineffective against either 
preventing the growth and development or the metastasis of 
the tumor, but when coadminsitered with the tumour cells it 
effectively inhibited metastasis[31].
5. Bee venom in cancer therapy
   Bee venom, a complex mixture of substances, is used to 
defend the bee colony against a broad diversity of predators 
from other arthropods to vertebrates. Bee venom, produced 
in the venom gland located in the abdominal cavity, 
contains several biologically active peptides, including 
melittin, apamin, adolapin, mast cell degranulating peptide 
and many enzymes, plus also non-peptide components, 
such as histamine, dopamine, phospholipase A2 (PLA2) and 
norephnephrine[81,82]. Bee venom has traditionally been used 
as a non-steroidal anti-inflammatory drug for the relief of 
pain and the treatment of chronic inflammatory diseases, 
such as rheumatoid arthritis and multiple sclerosis, as well 
as in the treatment of tumors[83-86].
   Bee venom inhibits the proliferation of carcinoma cells 
and tumor growth in vivo due to the stimulation of the local 
cellular immune responses in lymph nodes[83,87-89]. The 
mechanism of action of bee venom involves apoptosis, 
necrosis and lysis of the tumor cells[87-89]. Current research 
shows that bee venom induces apoptosis in human 
leukemic cells, but not in murine bone marrow cells, via the 
induction of Bcl-2 and caspase-3 expression through the 
downregulation of mitogen-activated signal pathways[90]. 
Bee venom has also been reported to induce apoptosis 
through caspase-3 activation in synovial fibroblasts[91] and 
to inhibit cyclooxygeneses-2 expression in human lung 
cancer cells[87].
   Melittin is the major protein component in bee venom, 
comprising some 40%-60% of the venom, and is the principal 
toxin causing inflammation, pain and sensitivity[85], but has 
also attracted considerable attention for its potential use 
in cancer therapy[92]. Melittin is a water soluble, cationic, 
amphiphilic α-helical peptide of 26 amino acid residues that 
is known to exert a variety of membrane-pertubing effects, 
such as hemolytic and antimicrobial activity[93]. Melittin can 
also induce structural alterations of membranes, including 
pore formation, fusion and vesiculation, which ultimately 
lead to hormone secretion, aggregation of membrane 
proteins, and a change in the membrane potential, but 
this action is equally effective against normal cells[94-97]. 
Moreover, melittin is a potent inhibitor of calmodulin (and 
so cell growth) and can stimulate a diverse array of signal 
transduction enzymes, including G-proteins, protein kinase 
C, adenylate cyclase, PLA2 and phospholipase C[95-98]. Within 
G-protein mediated signal transduction, melittin directly 
stimulates nucleotide exchange by heterotrimeric GTP 
activity by reducing the affinity of both GTP and GDP to Gs[99]. 
These diverse effects suggest that melittin exerts multiple 
effects on cellular functions. Although it was of interest 
that melittin binds to some cancer cells at a higher affinity 
than to normal cells, and so potentially allowing a low dose 
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selectivity for action against the transformed cells than 
normal cells[100,101], the current use of melittin is based upon 
target specific nanoparticle delivery.
   The activation of PLA2 can have a cytotoxic effect on cancer 
cells through several subsequent cellular changes. Melittin-
induced cell necrosis was ameliorated by a calpain protease 
inhibitor, which suggests that PLA2-mediated calpain 
activation might be a therapeutic strategy for inhibiting 
cancer cell growth by melittin, since the TNF-α-induced 
activation of cytosolic PLA2 is an important component of 
the signaling pathway leading to cell death[102]. Moreover, 
melittin increased the membrane permeability of L1210 cells 
and so perturbed the membrane integrity.
   Tumor metastasis is a complex process involving extensive 
interactions between the tumor cells and host tisues, but it is 
the major cause of death in cancer patients as well as in the 
limitation of relatively simple treatments (localised chemo- 
and/or radio-therapy or surgical tissue removal) compared 
to systemic treatment. It can be roughtly divided into the 
four steps of (i) tumor cell dissociation, (ii) intravasation and 
crudation, (iii) arrest and extravasation and (iii) adhesion, 
angiogenesis and proliferation[103]. Bee venom has been 
shown to directly inhibit the invasive and migratory 
ability of human breast (epithelial) cancer MCF-7 cells via 
the suppression of MMP-9 expression, and this could be 
mimicked by melittin, but not by apamin and PLA2. Thus, 
the specific inhibition of MMP-9 by bee venom is likely to be 
mediated by melittin alone or perhaps in conjunction with 
other less common compounds[98]. These results indicate 
that bee venom is a potential anti-metastatic and anti-
invasive agent that may merit future clinical research on its 
potential anti-cancer properties.
6. Conclusions
   Several bee products have been found to have anticancer 
activity in vitro on a range of tumor cell lines, including 
renal, lung, prostate, bladder, melanoma, osteosarcoma, 
mammary and lymphoid cancer derived cell lines. In 
addition, most of the reports on the mechanism of action of 
bee products in inhibiting tumor growth in vitro and in vivo 
suggest it is mediated via apoptosis, necrosis, and lysis of 
the tumor cells.  
   Honey and cancer have a sustainable inverse relationship 
in the setting of developing nations, where resources for 
the production of honey (and to a certain extent other bee 
products) are plentiful but resources for standard cancer 
prevention are limited. The mechanism on how bee products 
induce apoptosis and cell-cycle arrest is still of great 
interest for future research.
   Propolis induces apoptosis pathways in cancer cells, 
with CAPE and chrysin being identified as the two main 
agents that are the cause of the antiproliferative effect by 
changingthe expression of cancer relating genes. 
   Royal jelly affected the N-acetylation and inhibited the 
metabolism of 2-AF in the human liver tumor cell line in a 
dose-dependent manner and also decreased the profile of 
2-AF metabolites in J5 cells.
   Bee venom has been widely used in the treatment of some 
immune-related diseases as well as tumor treatments in 
modern days. Several cancers cells can be the potential 
targets of bee venom peptides, mediated through PLA2 
inhibitors, such as melittin. The cell cytotoxic effects 
mediated through the activation of PLA2 by melittin have 
been suggested to be the critical mechanism for the anti-
cancer activity of bee venom.
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Comments 
Background
   Some bee products such as honey and propolis have been 
used as medicines against human diseases in the world. In 
the present research, authors have summarized the recent 
various knowledge concerning the bioactivities of the 
products, especially anticancer activity.
  
Research frontiers
   This research is dealing with the relationship between 
honeybee products and the cancer being regarded as one of 
the most serious diseases nowadays, from the point of view 
of anticancer activity of honey, propolis, royal jelly, and 
bee-venom, respectively.
Related reports
   Some plant species produce characteristic antibiotics to 
protect themselves from various enemies. Some honeybee 
species collect the antibiotics for protecting themselves 
and their nest, that is, propolis. Therefore there have been 
many reports concerning propolis, however, with very few 
reports regarding the relation between propolis and tumor 
cells so far.
Innovations and breakthroughs
   One of the honeybee products is propolis which has been 
well known to have various effective bioactivities. In the 
present study, authors have indicated enlighteningly that a 
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certain propolis should have the anticancer activities.
  
Applications
   This valuable research survey shows that some of the 
honey products such as propolis have notable anticancer 
activity for men, and would encourage further actual 
applications.  
Peer review
   Having read through the present manuscript, I could 
interpret that the authors dealt with the bee products from 
the honeybees species belonging to the subfamily Apinae, 
which contains less than 10 species. There are two types of 
beekeeping in the world. One is called Apiculture which 
keeps Apinae bees. The other is Meliponiculture where bees 
belonging to the subfamily Meliponinae, which contains 
about 400 species. Meliponinae bees also produce honey 
and propolis which have been utilized for people widely in 
tropical and subtropical areas.
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